Let K be a complete discretely valued field of characteristic 0 with residue field κ of characteristic p. Let n = [κ : κ p ] be the p-rank of κ. It was proved in [PS14] that the Brauer p-dimension of K lies between n/2 and 2n. For n ≤ 3, we improve the upper bound to n + 1 and provide examples to show that our bound is sharp. For n ≤ 2, we also improve the lower bound to n. For general n, we construct a family of fields Kn with residue fields of p-rank n, such that Kn admits a central simple algebra Dn of index p n+1 . Our sharp lower bounds for n ≤ 2 and upper bounds for n ≤ 3 in combination with the nature of these examples motivate us to conjecture that the Brauer p-dimension of such fields always lies between n and n + 1.
Let k be a field of characteristic not 2. We give a positive answer to Serre's injectivity question for any smooth connected reductive k-group whose Dynkin diagram contains connected components only of type A n , B n or C n . We do this by relating Serre's question to the norm principles proved by Barquero and Merkurjev. We give a scalar obstruction defined up to spinor norms whose vanishing will imply the norm principle for the non-trialitarian D n case and yield a positive answer to Serre's question for connected reductive k-groups whose Dynkin diagrams contain components of non-trialitarian type D n also. We also investigate Serre's question for reductive k-groups whose derived subgroups admit quasi-split simply connected covers. arXiv:1511.00311v2 [math.AG]
Let F be the function field of a curve over a p-adic field. Let D/F be a central division algebra of prime exponent ℓ which is different from p. Assume that F contains a primitive ℓ 2 th root of unity. Then the abstract group SK 1 (D) :
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.